I think it is a good possibility. Why would the FDA allow the continued use? I think there are some things happening behind the scenes that the public simply doesn’t know about yet. But IMO will happen soon.
When I was reviewing time lines of applications to other countries for EUA’s we are nearing the earliest time compared to length of time it took others. Given the pandemic, variants, proven potential and proven safety of Leronlimab, the dam is about to burst.